INTRODUCTION
The skin is the largest organ in mammals, consisting of three layers, epidermis, dermis and hypodermis, with associated appendages, including hair follicles, sebaceous and sweat glands. The biology of epidermal stem cells in the skin is well known (Blanpain and Fuchs, 2009; Baker and Murray, 2012) . In particular, the pilo-sebaceous unit (hair follicle and associated glands) and the hair follicle growth cycle constitute a very well characterized model to study the functional regulation of skin stem cells. The hair follicle is a complex mini-organ that invaginates from epidermal sheets of the skin into the dermis (Muller-Rover et al, 2001; Baker and Murray, 2012; Gilhar et al, 2012) . Hair production is the result of a cyclic activity of the hair follicle alternating three sequential phases:
anagen (growth), catagen (cessation and regression) and telogen (rest). The hair follicle is divided in two main regions depending on size variation rates through the hair cycle: permanent and cyclic regions. The upper permanent region, composed by the infundibulum, associated glands and the bulge, a major reservoir of hair follicle stem cells, regulates the activity of the dermal papilla in the cyclic region (Ramos et al, 2013) . Activation of dermal papilla cells during the anagen phase promotes extensive cell proliferation and differentiation in the cyclic region, ultimately resulting in the formation and growing of the hair shaft. Skin components are constantly renewed by a stock of multipotent epidermal stem cells, located in the bulge region of the hair follicle and in the basal layer of the inter-follicular epithelium (Blanpain and Fuchs, 2009; Baker and Murray, 2012) .
Important and well known molecular mechanisms, including Wnt/β-catenin, BMP/Tgfβ/Smad, PI3K/Akt and ERK/MAPK signalling pathways (Baker and Murray, 2012; Lopez-Pajares et al, 2013; Ramos et al, 2013) , have key roles in the regulation of different aspects of skin stem cell and hair follicle function.
However, skin homeostasis and the hair follicle cycle are extremely complex and multifactorial processes. Many of the interplaying mechanism that govern and/or modulate the functional output of these processes are not well characterized. In particular, the potential physiological role of reactive oxygen species (ROS) in the skin is largely unknown.
The generation of reactive oxygen species (ROS) as by-products of essential and efficient metabolic reactions, such as cellular respiration or oxidase activity, is an inevitable biochemical side-effect that can be extremely harmful for cell viability. The oxidative stress induced by the undesirable intracellular accumulation of ROS is a major cause of cell and tissue toxicity and it is associated with several human diseases, including neurodegenerative (Parkinson's, Alzheimer's and Huntington's diseases), psychiatric (schizophrenia and bipolar disorder) and cardiovascular (stroke and myocardial infarction) disorders (Pieczenik and Neustadt, 2007; Valko et al, 2007) . ROS are also implicated in sickle cell disease and the fragile X and chronic fatigue syndromes (el Bekay et al, 2007; Pieczenik and Neustadt, 2007) . The so called oxidative stress or free radical theory of aging proposes a causal link between gradual, time-dependent ROS production during the whole lifetime and aging of the organism, a controversial theory that remains the subject of intense debate (Perez et al, 2009; Speakman and Selman, 2011) .
Aerobic organisms have evolved powerful mechanisms to manage excess ROS production and are able to efficiently detoxify superoxide anions, hydroxyl radicals, hydrogen peroxide and organic hydroperoxides into harmless H 2 O and O 2 . These mechanisms are exemplified by the superoxide dismutase, catalase, and glutathione peroxidase enzymatic systems (Machlin and Bendich, 1987; Fernandez and Videla, 1996; Mates and Sanchez-Jimenez, 1999) .
Interestingly, in the course of evolution, eukaryotic organisms have also developed systems to use ROS production for their own benefit. An example is the phagocyte, an essential cell player of the mammalian immune system that can produce radical oxygen and nitrogen species in a tightly controlled way to kill target pathogens (Klebanoff et al, 1983; Bylund et al, 2010) .
Accumulated evidence suggests that eukaryotic cells can also actively promote the production of small amounts of ROS as part of signalling pathways that regulate cell survival and proliferation (Droge, 2002 , Chiarugi and Cirri, 2003 , Bartosz, 2009 , Sena and Chandel, 2012 . Furthermore, it has been reported that exogenous ROS can regulate stem cell function in in vitro systems (Le Belle et al, 2010 ). An abnormal ROS production has been also linked to the deregulation of intestinal stem cell proliferation that occurs during colorectal cancer initiation (Myant et al, 2013) . These observations imply the existence of widespread ROS-dependent mechanisms for the regulation of cell function and tissue homeostasis. Here we have used the skin and the well characterized epidermal stem cell niche located in the bulge region of the mouse hair follicle as a working model to provide a proof-of-concept for the hypothesis that a transient modulation of in situ ROS levels can regulate skin homeostasis and stem cell function in a whole organism.
RESULTS
-Photodynamic treatment of mouse skin with mALA and red light induces a transient in situ ROS production in the tissue.
To this end we first developed a reproducible method to promote a controlled and transient increase of ROS in the skin. High levels of intracellular ROS can be generated by a combination of light of an adequate wavelength and a photosensitizer (PS) in the presence of O 2 (Juarranz et al, 2008) . The resulting photodynamic effect ( Figure S1a ) is widely used as a powerful cell killing method in clinical practice (photodynamic therapy) for the treatment of several skin diseases, including cancer and infections. At present, 5-aminolevulinic acid (ALA) or its methyl derivative (mALA) in combination with red light is the most widely used photodynamic therapy in the clinic. These compounds are not PS per se, but function as precursors of the endogenous PS Protoporphyrin IX (PpIX) ( Figure S1b ) (Juarranz et al, 2008) .
We have previously demonstrated that mALA can be used to photo-generate tightly controlled low levels of intracellular ROS that are able to stimulate cell proliferation instead of cell death in cultured immortalized keratinocytes (Blazquez-Castro et al, 2012) . Here, we have adapted this approach to mouse skin in vivo. We have evaluated irradiation doses from 2 to 10 J/cm 2 and a fixed mALA concentration (25 mg Metvix ® , mALA 160 mg/g cream). We found that topical application of mALA on mouse dorsal skin promoted an extensive production and accumulation of PpIX in the tissue, as revealed by the characteristic reddish fluorescence of this compound under blue light (407 nm) excitation ( Figure 1a ). As expected, mALA-dependent PpIX accumulation in the skin followed by 2.5 J/cm 2 irradiation with red light (636 nm) to complete the photodynamic treatment (mALA+Light) resulted in a significant increase of in situ ROS levels in the tissue (Figure 1b) . A time-course analysis showed that relative ROS production was transient, returning to initial levels 100 min after irradiation ( Figure 1b) . To gain further detail on the distribution of generated ROS in the tissue we used the manageable mouse tail skin epithelium.
Accordingly, experimental treatments and the localization of PpIX and ROS were evaluated ex vivo in whole pieces of the tissue. We established that incubation with mALA resulted in a significant accumulation of PpIX in the hair follicle (Figure 1c ), followed by a notable production of ROS after 10 J/cm 2 of red light irradiation (mALA+Light) that was detected to some degree all over the epidermis, including IFE, infundibulum and sebaceous glands ( Figure 1d ).
Notably, ROS signal rapidly disappeared or declined in most tissue locations, persisting for longer times in bulge cells (Figure 1d ), which is the main niche or reservoir of epidermal stem cells in the skin. As these experiments were performed ex vivo to determine ROS localization, the time course of ROS production is not comparable to that observed in vivo in back skin. However, these results corroborate the transient nature of ROS production in the skin induced by our experimental approach, as well as the remarkable incidence on the bulge stem cell niche.
To rule out deleterious effects of our protocol on cell and tissue viability we used different approaches. We analysed the formation of phosphorylated histone H2AX (pH2AX; also known as gammaH2AX) foci on the chromatin fibre that are associated with severe DNA damage (Yuan et al, 2010) . No significant differences were observed in the number and distribution of pH2AX positive cells in the skin in samples irradiated with red light after mALA application, as compared to light control samples ( Figure S2a ). In sharp contrast, a strong increase in the number of cells showing pH2AX foci was observed in UV irradiated skin ( Figure S2a ). In the same way, we found that mALA+Light was unable to induce a noticeable increase in the number of apoptotic cells in the interfollicular epithelium or in the hair follicle ( Figure S2b ). Finally, we also evaluated whether our protocol could alter the incidence of skin tumour formation. We performed two series of experiments involving a single mALA+Light (n=5) or a dual treatment in a 15 day period (n=3). In both cases, our results indicated that the mALA+Light treatment was completely safe and had no detectable or significant capacity to induce tumours in long-term experiments (up to 18 months).
-Switching on in situ ROS production in the skin activates cell proliferation in epidermal and dermal layers and in the hair follicle stem cell niche.
We next investigated the potential effects of the transient ROS increase induced by mALA+Light on the function of epidermal stem cells in the bulge region of the hair follicle. To this end, we first proceeded to identify stem cells as label retaining cells (LRC) in pulse and long-chase experiments with the nucleotide analogue 5-bromo-2´-deoxyuridine (BrdU) (Braun et al, 2003) . We (Morris et al, 2004) . We found a significant increase of GFP positive cells in the bulge region of the hair follicle 2 days after mALA+Light that returned to normal levels 6 days after the treatment ( Figure S3 ).
We also observed that mALA+Light promoted a transient increase in the number of proliferating cells in the epidermal and dermal layers of the skin starting 2 days after the treatment and returning to normal levels by day 6 (Figure 2c ; Figure S4a ). This proliferative pulse was associated with a transient epidermal hyperplasia and a significant increase of dermal cellularity 2 days after treatment that disappeared by day 6 (Figure 2c ; Figure -Switching on in situ ROS production in the skin stimulates hair growth and accelerates burn healing.
We reasoned that the effect of mALA+Light on cell proliferation in the skin and, particularly, on stem cells contained in the hair follicle bulge region should produce a physiological response in the target tissue. Supporting this concept, we observed that mALA+Light strongly promoted hair growth after shaving stimulation during the refractory telogen phase ( Figure 3a ; Figure S5a ).
Importantly, the use of anti-oxidant compounds like ascorbic acid (AA) and N-acetylcysteine (NAC) abolished the differences in hair follicle growth rates induced by mALA+Light with respect to Light control skin ( To get a deeper insight into the molecular mechanism underlying the ROS-dependent, Src-driven activation of the epidermal stem cell niche we performed a series of large-scale microarray analyses of mRNA expression, both in back and tail epidermis after mALA+Light as compared to control samples (GEO accession number GSE55135). Several genes showed significant transcriptional alterations 2 days after mALA+Light that were similarly modulated in tail and back epidermis (Table 1) . It is to note that this large-scale analysis showed that mALA-PT was not associated with transcriptional profiles of inflammation or injury response. The transcriptional profiles of genes of interest were validated in all cases by qRT-PCR in dorsal skin at both 2 or 6 days after mALA+Light (Figure 5c ), revealing that the majority of genes transcriptionally altered at 2 days returned to normal expression levels 6 days after the treatment. In agreement with our previous observations, targets of Wnt/β-catenin signalling in the skin, such as Jag1, Ovol1 and Axin2, were transcriptionally repressed 2 days after mALA+Light (Figure 5c ). Interestingly, the strongest transient transcriptional activation induced by mALA+Light was observed for members of the prolactin family 2 subfamily c of growth factors. In particular, Prl2c3, also known as proliferin-2, showed a marked transient activation 2 days after switching on ROS production by mALA+Light (Table 1 ; Figure 5c ). More surprisingly, we found a significantly increased expression of Prl2c3 protein in the skin associated with a strong nuclear localization in the hyperplastic interfollicular epidermis (Figure 5d ). proliferation that occurs during colorectal cancer initiation (Myant et al, 2013) . In these studies an exogenous and/or continuous ROS supply or a systemic ROS depletion is used to evaluate a specific effect on a tissue or biological systems.
DISCUSSION
As a complement to these studies, our experimental approach implies a local and transient activation of endogenous ROS production using the molecular machinery of the tissue. In this sense our results are in close consonance with the observation that a transient ROS production occurs during tail regeneration in Xenopus tadpoles (Love et al, 2013) . In this report it is shown that activation In the same context, the molecular mechanisms regulating Src kinase activity by ROS in cultured cells are well characterized (Giannoni et al, 2010 ). These observations suggest that Src activity, independently or in combination with a controlled ROS production, can be an important partner in the skin signalling network, which merits further investigation. In this context, we hypothesize that mALA-PT induces 2 days after treatment an initial, cSrc-dependent, proliferative wave in the skin able to activate hair follicle stem cell niches. This activation results in standard, Lef1 dependent, anagen entry around 6 days after treatments.
We have further shown that a transient ROS production switching on in the skin promotes a strong and unexpected transcriptional activation of prolactin family 2 subfamily c gene members, particularly Prl2c3. Surprisingly, we found that Prl2c3 was significantly translocated to the nucleus in most cell layers in the hyperplastic epithelium after mALA+Light, suggesting that this hormonelike protein can have nuclear functions. Interestingly, it has been reported that this mitogen is expressed in the hair follicle anagen growth phase (Fassett and Nilsen-Hamilton, 2001 ) and facilitates the expansion of hematopoietic stem cells ex vivo (Choong et al, 2003) . The role of Prlc3 in the skin is currently under investigation. In this context, the procedure presented here to transiently activate endogenous ROS production in the skin has proved to be an efficient tool not only to suggest a physiological role for ROS in vivo but also to identify new signalling pathways and factors potentially implicated in the regulation of skin homeostasis.
MATERIALS AND METHODS

Animals
Seven-week-aged C57BL/6 mice, including the strain B6.Cg-Tg(Krt1-15-EGFP)2Cot/J (Morris et al, 2004 ), were used. When possible, littermates were included in each experiment and comparisons were done between animals of the same sex. Both males and females were used in experiments using tail skin. Only females were used in experiments performed in back skin. All animal husbandry and experimental procedures were conducted in compliance with 2010/63/UE European guideline or approved by the Subcommittee on Research Animal Care (IACUC) of Massachusetts General Hospital (Boston, MA), in accordance with the guidelines of the National Institutes of Health (NIH).
Identification of Label Retaining Cells (LRC) in tail skin epithelium
Long-term 5-bromo-2'-deoxyuridine (BrdU; Sigma-Aldrich) label retaining cells (LRC) were generated and characterized as previously described (Braun et al, 2003) . Briefly, ten-day-old mice were injected intraperitoneally (i. p.) once a day during 4 consecutive days with 50 mg/kg bodyweight BrdU dissolved in PBS. After the labelling phase, mice were allowed to grow until the age of 7 weeks before any treatment. To prepare whole-mounts of tail epidermis, tails were clipped, skin was peeled from tails and incubated in 5 mM EDTA in PBS 4 h at 37 ºC. Intact sheets of epidermis were separated from the dermis using forceps and fixed in 4% formaldehyde in PBS.
Burning procedure
For induction of burn injuries, mice were anesthetized and shaved. A brass bar (1 cm in cross-section) pre-heated (~95 ºC) by immersing in boiling water was applied on the dorsal surface of each mouse and maintained in contact with the skin for 5 seconds. The resulted nonlethal, partial-thickness, 2 nd degree burns measured approximately 1.3-cm × 1.3-cm. For the analysis of proliferating cells around the wound, animals received 2 sequential i. p. injections of 50 mg/kg bodyweight BrdU every 12 hours, starting 4 h after mALA-PT.
Photodynamic treatments
All experiments were performed during the refractory telogen phase of the hair follicle growth cycle (7-week-old mice). For photodynamic treatments, mALA as topical cream (Metvix ® , Galderma) was used. For tail skin experiments, Metvix ® was applied directly on the skin. For back skin treatments, animals were completely shaved with a hair clipper and depilatory cream (Veet ® ) and washed with PBS. We applied 25 mg of Metvix ® covering the area of interest. After 2.5 h of incubation in darkness, animals were anesthetized and the accumulation of PpIX was evaluated in situ by measuring the characteristic red fluorescence under 407 nm blue light excitation. To conduct the photodynamic treatments (mALA+Light), a red light (636 nm) emission was subsequently applied on the dorsal surface of the tissue to a total dose of 2.5-10 J/cm 2 , using a LED lamp (Aktilite ® ). Light control animals received only red light, while Dark control animals received only mALA and they were kept in dark at least 48 h after the treatment. For inhibitory experiments using ascorbic acid (AA, from Sigma), two doses of 100 mg/ml AA in 50% ethanol spaced 30 min were topically applied on the skin between the application of mALA and red light irradiation. For the alternative experiments using N-acetylcysteine (NAC, from Sigma), a solution containing 20 mg/ml NAC in PBS was i.p. inoculated daily during 5 days at a dose of 100 mg/kg bodyweight, until the day that mALA-PT was applied. Photodynamic treatments on burned skin were performed 24 h after the burning procedure. In all cases, the % of animals showing hair growth acceleration in treated back skin regions as compared to control regions in the same animal was evaluated. An animal showing hair growth acceleration was defined as an animal showing full hair growth all along the treated region, typically by days 12-19 after shaving, but only limited or no hair growth in the control region.
Monitoring ROS production
ROS production in tail skin was evaluated ex vivo using hydroethidine (SigmaAldrich), which reacts with ROS to produce fluorescent dye hET. Samples were incubated at 37 ºC for 3 h in a solution with 5 mM EDTA in PBS, containing 2 mM mALA in the case of treated samples. Hydroethidine was added to a final concentration of 3.2 µM. After 1 h, the skin was irradiated with 10 J/cm 2 of 636 nm light and fixed.
For in vivo detection of ROS produced in back skin during photodynamic treatment, the ROS sensitive DHF-DA (Sigma-Aldrich) was used. In order to assess the inhibitory effect of AA, two independent groups of animals were established for each time point for normalizing the obtained signal (mALA+Light/Light) with respect to AA-animals. After dorsal skin shaving and PT treatment application as previously described (Metvix ® 2.5 h in dark followed by the irradiation with 2.5 J/cm 2 of 636 nm light), 1 mg/ml DHF-DA in 50% ethanol was topically applied on the tissue at different time points after the irradiation (5, 20 and 100 min). ROS levels generated in the skin were determined 45 min after the application of DHF-DA in all cases, using an IVIS ® Lumina 2 imaging system (Xenogen), by measuring the fluorescent signal emitted by the fluorescein produced through the oxidation of DHF-DA. The filters setting were 445-490 nm for the excitation and 515-575 nm for the emission.
Immunological and histological methods
Primary antibodies used were FITC-conjugated mouse monoclonal anti BrdU (Roche); rabbit monoclonal antibodies against Src, Phospho-Src (Tyr416), AKT, Phospho-AKT (Ser473), p38 MAPK, Phospho-p38 MAPK (Thr180/Tyr182), p44/42 MAPK, Phospho-p44/42 MAPK (Thr202/Tyr204), Phospho SAPK/JNK (Thr183/Tyr185) and gammaH2AX (Ser 139) and Lef1 (all from Cell Signaling Technologies); rabbit monoclonal anti Ki67 (Neo Markers); rabbit polyclonal anti Src (Abcam); mouse monoclonal anti β-catenin (BD); mouse monoclonal anti Active-β-catenin (Millipore); goat polyclonal anti-Proliferin 2 (Prl2c3) and anti-MPO (both from Santa Cruz Biotechnology); mouse monoclonal antibodies against PCNA (Calbiochem), tubulin and BrdU (both from Sigma).
For BrdU-FITC immunostaining in tail skin epithelium whole-mounts, fixed epidermal pieces were sequentially treated with 1 N HCl 45 min at 37 ºC, Trisborate-EDTA 5 min at RT and washed abundantly with distilled water. Permeabilization and blocking were carried out by incubation with PTG buffer (PBS containing 0.5% Triton X-100 and 0.2% gelatin) for 30 min at RT. Then, samples were incubated with the FITC-conjugated primary antibody against BrdU (Roche) diluted 1:50 in PBS, overnight at 37 ºC. For fluorescence immunostaining of pH2AX, positive control samples were obtained from animals exposed to a total dose of 7.44 J/cm 2 of UVB light, using a lamp with a 312 nm emission peak (Philips TL UV). Apoptosis was detected in whole-mounts using the TUNEL detection kit (Roche) following the instructions of the manufacturer. Images were obtained in Leica TCS SP2 AOBS spectral confocal microscope and processed using FIJI software.
For immunohistochemical staining, hydrated paraffin samples were treated with tripsin (Thermo Scientific) 30 min at 37 ºC before incubating overnight with primary antibodies and revealed using the Envision Flex/HRP (Dako) secondary antibodies cocktail and DAB kit (Vector Laboratories).
For immunobloting, skin samples were homogenized at 4 ºC in cold NT lysis buffer (50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl 2 , 5 mM CaCl 2 , 1% NP-40, 1% Triton X-100, 2 mM, PMSF, 20 µg/ml aprotinin and 1 mM sodium orthovanadate).
RNA extraction and gene expression analysis
RNA was isolated form back skin and back and tail epidermis with TriPure TM Isolation Reagent (Roche) and RNeasy Mini kit (QIAGEN). Gene expression signatures were characterized using standardized mouse global mRNA expression arrays (Agilent Technologies; Agilent.SingleColor.14868). Gene expression analysis included pool samples (n=3) obtained 2 days after the treatment. Pools prepared from both back and tail epidermis were independently analysed. Large-scale gene expression results were validated by real-time quantitative RT-PCR (qRT-PCR) in back skin samples. Primer sequences are available upon request.
Statistical analysis
Quantifications of LRC and Krt1-15-GFP expression in the bulge region were performed on confocal images (30 hair follicles/animal, 3 animals/group). BrdU positive cells were quantified in the 3 hair follicles closest to the burned area in 3 different animals per condition. Comparisons between groups were performed by Student's t test using the SPSS 15.0 software. Skin thickness was measured in 10 different regions of interfollicular epidermis per mouse including 3 animals per condition.
In vivo ROS production detected with the IVIS ® Lumina 2 was quantified using FIJI software. The relative DHF-DA Integrated density was calculated for each mouse as the ratio of the integrated density obtained in mALA-treated skin related to Light control area. For the statistical comparison, the integrated density was normalized calculating the ratio (vehicle/AA) for all possible pairs between AA and vehicle-treated animals for each time point. The average and standard error (SE) were represented and means of different time points were compared using ANOVA.
For statistical analyses of gene expression data, an unpaired t-test was applied, setting p≤0.05 and fold change ≥2.0 as limits for significance. qRT-PCR data were analysed by a comparative C T method, using 18S rRNA expression as internal control. Gene expression fold changes were represented as the ratio between means of 2 -∆Ct values of mALA+Light and Light control groups mean values. Differentially expressed genes were selected based on the Student's t test comparison of means of 2 -∆Ct values between both groups.
For quantification of burn assays, day-to-day digital images were analysed. The unhealed area was quantified using FIJI software. The area-under-the-curve was calculated separately for each mouse and means were compared by the Student's t test. of the anti-oxidant AA (n=4 in 3 independent experiments). c) Quantification of the ROS production inhibition in dorsal skin induced by AA during mALA-PT (n=4, DHF-DA was applied 20 min after irradiation). d) Inmunohistochemical detection of the PCNA proliferation marker in dorsal skin histological sections 2 days after mALA-PT showing inhibition of cell proliferation by the anti-oxidant AA. e) Inmunolocalization of Lef1 (arrowheads) in equivalent hair follicle wholelength reconstructions generated from confocal microscopy images (maximum projections) 6 and 10 days after treatments in mALA+Light and control Light treated skin and in non-treated skin (normal anagen, NA). f) Dorsal skin histological sections stained for inmunohistochemical detection of the PCNA proliferation marker 10 days after mALA-PT showing extensive cell proliferation in different regions of growing anagen hair follicles (arrowheads). Bars: 100 µm. Figure S1 . Photodynamic production of ROS using the heme biosynthetic pathway. a) Schematic representation of photochemical reactions during typical photodynamic treatments. O 2 ) drives the formation of the non-radical but highly reactive singlet oxygen ( 1 O 2 ). The photoproducts formed during these reactions trigger a cascade of biochemical events resulting in an oxidative stress that finally causes cell death or that can potentially stimulate cell growth. b) 5-aminolevulinic acid (ALA) is a natural precursor in the heme biosynthetic pathway, which involves both mitochondrial and cytosolic cellular compartments. The ALA synthase enzyme activity is regulated by a negative feedback control whereby free heme, the final product of this pathway, inhibits the synthesis of ALA from glycine and succinyl CoA. The administration of exogenous ALA or its derivative methyl aminolevulinate (mALA) bypasses the regulatory feedback system, so that downstream metabolites, especially Protoporphyrin IX (PpIX), are accumulated in the cell inducing photosensitization. The rate-limiting characteristics of ferrochelatase, catalyst enzyme of the iron insertion in PpIX, promote the accumulation of this endogenous PS compound. Figure S2 . Switching on in situ ROS production in the skin does not induce molecular markers associated with DNA damage or apoptosis. a) Immunolocalization of the pH2AX protein on tail skin samples irradiated with 312 nm light (UV), 636 nm red light (Light control) or treated with mALA+ red light (mALA+Light). Extensive formation of pH2AX nuclear foci in interfollicular epithelium cells was observed in UV treated samples but not in Light control or mALA+Light samples. b) Detection of apoptotic cells by TUNEL on tail skin in Light control samples from 15 hours to 6 days after mALA+Light. No significant differences in the number of apoptotic cells were observed after mALA+Light treatments as compared to control samples. In all cases are shown representative confocal microscopy images (maximum projections) corresponding to whole-mounts of tail skin epidermis. Bars: 50 µm. Figure S3 . Switching on in situ ROS production in the skin activates stem cell proliferation in the hair follicle niche. Detection and quantification of cells expressing GFP under the control of the keratin1-15 promoter (Krt1-15-GFP), a marker of epidermal stem cells, in the bulge region of the hair follicle. Tail skin samples were obtained 2 (a) or 6 (b) days after Light and mALA+Light treatments. The integrated density of GFP expression in the bulge region from at least 30 hair follicles in three different mice was calculated as described in Materials and Methods, and the mean +/-SE is represented. Images correspond to maximum projections of confocal microscopy reconstructions from tail skin whole-mounts. Bar: 100 µm. 
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